Recent Events & Catalysts
Mirum Pharmaceuticals, Inc. (MIRM) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
TD Cowen Maintains Buy on Mirum Pharmaceuticals, Lowers Price Target to $140
Benzinga · 5d ago
RBC Capital Maintains Outperform on Mirum Pharmaceuticals, Lowers Price Target to $135
Benzinga · 5d ago
Citizens Maintains Market Outperform on Mirum Pharmaceuticals, Lowers Price Target to $137
Benzinga · 5d ago
HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Lowers Price Target to $140
Benzinga · 5d ago
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2026 Earnings Call Transcript
SeekingAlpha · 5d ago
Mirum Pharmaceuticals (NASDAQ:MIRM) Slides on Wider Loss and Volixibat Delay Despite Revenue Beat
ChartMill · 6d ago
Wondering what's happening in today's after-hours session?
ChartMill · 6d ago
CORRECTION: Mirum Pharmaceuticals Q2 Adj. EPS $(0.80) Misses $(0.68) Estimate, Sales $176.243M Beat $166.122M Estimate
Benzinga · 6d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-05 · 6d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-18 · 54d ago
Entry into a material agreement, Creation of a direct financial obligation (new debt), Unregistered sales of equity securities, Other events, Financial statements and exhibits
Filed 2026-05-18 · 85d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.